Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis

Abstract: Introduction: Trimethylamine-N-oxide (TMAO) is correlated with atherosclerosis and vascular diseases as coronary heart disease and ischemic stroke. The aim of the study was investigate whether TMAO levels are different in symptomatic vs. asymptomatic cerebrovascular atherosclerosis. Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heyse, Miriam (VerfasserIn) , Tunkl, Christine (VerfasserIn) , Drüschler, Katharina (VerfasserIn) , Berberich, Anne (VerfasserIn) , Zorn, Markus (VerfasserIn) , Ringleb, Peter A. (VerfasserIn) , Okun, Jürgen G. (VerfasserIn) , Mundiyanapurath, Sibu (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 March 2021
In: Frontiers in neurology
Year: 2021, Jahrgang: 12
ISSN:1664-2295
DOI:10.3389/fneur.2021.617944
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fneur.2021.617944
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fneur.2021.617944/full
Volltext
Verfasserangaben:Miriam Heyse, Christine Schneider, Peter Monostori, Kathrin V. Schwarz, Jana Hauke, Katharina Drüschler, Anne Berberich, Markus Zorn, Peter A. Ringleb, Jürgen G. Okun and Sibu Mundiyanapurath

MARC

LEADER 00000caa a2200000 c 4500
001 1757052739
003 DE-627
005 20230426114233.0
007 cr uuu---uuuuu
008 210504s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fneur.2021.617944  |2 doi 
035 |a (DE-627)1757052739 
035 |a (DE-599)KXP1757052739 
035 |a (OCoLC)1264417764 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heyse, Miriam  |d 1988-  |e VerfasserIn  |0 (DE-588)1104853787  |0 (DE-627)86220383X  |0 (DE-576)472923730  |4 aut 
245 1 0 |a Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis  |c Miriam Heyse, Christine Schneider, Peter Monostori, Kathrin V. Schwarz, Jana Hauke, Katharina Drüschler, Anne Berberich, Markus Zorn, Peter A. Ringleb, Jürgen G. Okun and Sibu Mundiyanapurath 
264 1 |c 19 March 2021 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.05.2021 
520 |a Abstract: Introduction: Trimethylamine-N-oxide (TMAO) is correlated with atherosclerosis and vascular diseases as coronary heart disease and ischemic stroke. The aim of the study was investigate whether TMAO levels are different in symptomatic vs. asymptomatic cerebrovascular atherosclerosis. Methods: This was a prospective, case-control study, conducted at a tertiary care university hospital. Patients were included if they had large-artery atherosclerosis (TOAST criteria). Symptomatic patients with ischemic stroke were compared with asymptomatic patients. As primary endpoint, TMAO levels on admission were compared between symptomatic and asymptomatic patients. Univariable analysis was performed using Mann-Whitney-U test and multivariable analysis using binary logistic regression. TMAO values were adjusted for glomerular filtration rate (GFR), age and smoking. Results: Between 2018 and 2020, 82 symptomatic and asymptomatic patients were recruited. Median age was 70 years, 65% were male. Comparing symptomatic (n=42) and asymptomatic (n=40) patients, no significant differences were found in univariable analysis in TMAO (3.96 [IQR 2.30-6.73] vs. 5.36 [3.59-8.68] μmol/l; p=0.055), GFR (87 [72-97] vs. 82 [71-90] ml/min*1.73m2; p=0.189) and age (71 [60-79] vs. 69 [67-75] years; p=0.756). In multivariable analysis TMAO was not a predictor of symptomatic cerebrovascular disease after adjusting for age and GFR (OR 1.003 [95% CI: 0.941-1.070]; p=0.920). In a sensitivity analysis, we only analyzed patients with symptomatic stenosis and excluded patients with occlusion of brain-supplying arteries. Again, TMAO was not a significant predictor of symptomatic stenosis (OR 1.039 [0.965-1.120], p=0.311). Conclusion: TMAO levels could not be used to differentiate between symptomatic and asymptomatic cerebrovascular disease in our study. 
650 4 |a Atherosclerosis 
650 4 |a Carotid artery stenosis (CAS) 
650 4 |a cerebrovascular 
650 4 |a gut micriobiome 
650 4 |a ischemic stroke 
700 1 |a Tunkl, Christine  |d 1989-  |e VerfasserIn  |0 (DE-588)1082584290  |0 (DE-627)847686302  |0 (DE-576)455535906  |4 aut 
700 1 |a Drüschler, Katharina  |e VerfasserIn  |0 (DE-588)1132544726  |0 (DE-627)887869521  |0 (DE-576)488885930  |4 aut 
700 1 |a Berberich, Anne  |d 1988-  |e VerfasserIn  |0 (DE-588)1034064096  |0 (DE-627)743980654  |0 (DE-576)381718697  |4 aut 
700 1 |a Zorn, Markus  |d 1964-  |e VerfasserIn  |0 (DE-588)1033873721  |0 (DE-627)745111483  |0 (DE-576)381543137  |4 aut 
700 1 |a Ringleb, Peter A.  |e VerfasserIn  |0 (DE-588)1032676175  |0 (DE-627)73863364X  |0 (DE-576)172917743  |4 aut 
700 1 |a Okun, Jürgen G.  |d 1968-  |e VerfasserIn  |0 (DE-588)121578232  |0 (DE-627)705551415  |0 (DE-576)292781296  |4 aut 
700 1 |a Mundiyanapurath, Sibu  |d 1981-  |e VerfasserIn  |0 (DE-588)141949023  |0 (DE-627)704103419  |0 (DE-576)325724741  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in neurology  |d Lausanne : Frontiers Research Foundation, 2008  |g 12(2021) vom: März, Artikel-ID 617944  |h Online-Ressource  |w (DE-627)631498753  |w (DE-600)2564214-5  |w (DE-576)326550933  |x 1664-2295  |7 nnas  |a Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis 
773 1 8 |g volume:12  |g year:2021  |g month:03  |g elocationid:617944  |g extent:6  |a Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis 
856 4 0 |u https://doi.org/10.3389/fneur.2021.617944  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fneur.2021.617944/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20210504 
993 |a Article 
994 |a 2021 
998 |g 141949023  |a Mundiyanapurath, Sibu  |m 141949023:Mundiyanapurath, Sibu  |d 910000  |d 911100  |d 50000  |e 910000PM141949023  |e 911100PM141949023  |e 50000PM141949023  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 11  |y j 
998 |g 121578232  |a Okun, Jürgen G.  |m 121578232:Okun, Jürgen G.  |d 910000  |d 910500  |d 50000  |e 910000PO121578232  |e 910500PO121578232  |e 50000PO121578232  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 10 
998 |g 1032676175  |a Ringleb, Peter A.  |m 1032676175:Ringleb, Peter A.  |d 910000  |d 911100  |e 910000PR1032676175  |e 911100PR1032676175  |k 0/910000/  |k 1/910000/911100/  |p 9 
998 |g 1033873721  |a Zorn, Markus  |m 1033873721:Zorn, Markus  |d 910000  |d 910100  |e 910000PZ1033873721  |e 910100PZ1033873721  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1034064096  |a Berberich, Anne  |m 1034064096:Berberich, Anne  |d 910000  |d 911100  |e 910000PB1034064096  |e 911100PB1034064096  |k 0/910000/  |k 1/910000/911100/  |p 7 
998 |g 1132544726  |a Drüschler, Katharina  |m 1132544726:Drüschler, Katharina  |d 910000  |d 911100  |e 910000PD1132544726  |e 911100PD1132544726  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 1082584290  |a Tunkl, Christine  |m 1082584290:Tunkl, Christine  |d 910000  |d 911100  |e 910000PT1082584290  |e 911100PT1082584290  |k 0/910000/  |k 1/910000/911100/  |p 2 
998 |g 1104853787  |a Heyse, Miriam  |m 1104853787:Heyse, Miriam  |d 910000  |d 911100  |e 910000PH1104853787  |e 911100PH1104853787  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1757052739  |e 3922730302 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1757052739"],"doi":["10.3389/fneur.2021.617944"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"19 March 2021"}],"relHost":[{"disp":"Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosisFrontiers in neurology","pubHistory":["2008 -"],"recId":"631498753","note":["Gesehen am 18.08.20","Specialty sections: Autonomic Neuroscience; Brain Imaging Methods; Dementia; Endovascular and Interventional Neurology; Epilepsy; Headache Medicine and Facial Pain; Movement Disorders; Multiple Sclerosis and Neuroimmunology; Neurocritical and Neurohospitalist; Care; Neurodegeneration; Neurogenomics; Neurology Education; Neuromuscular Diseases; Neuro-Oncology; Neuro-Ophthalmology; Neuro-Otology; Neuropediatrics; Neuropharmacology; Neuroprosthetics; Neurotrauma; Sleep and Chronobiology; Spinal Cord Medicine; Sports Neurology; Stroke; Teleneurology"],"name":{"displayForm":["Frontiers Research Foundation"]},"id":{"eki":["631498753"],"zdb":["2564214-5"],"issn":["1664-2295"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2008-","publisherPlace":"Lausanne","publisher":"Frontiers Research Foundation","dateIssuedKey":"2008"}],"part":{"text":"12(2021) vom: März, Artikel-ID 617944","volume":"12","extent":"6","year":"2021"},"titleAlt":[{"title":"Autonomic Neuroscience"},{"title":"Brain Imaging Methods"},{"title":"Dementia"},{"title":"Endovascular and Interventional Neurology"},{"title":"Epilepsy"},{"title":"Headache Medicine and Facial Pain"},{"title":"Movement Disorders"},{"title":"Multiple Sclerosis and Neuroimmunology"},{"title":"Neurocritical and Neurohospitalist Care"},{"title":"Neurodegeneration"},{"title":"Neurogenomics"},{"title":"Neurology Education"},{"title":"Neuromuscular Diseases"},{"title":"Neuro-Oncology"},{"title":"Neuro-Ophthalmology"},{"title":"Neuro-Otology"},{"title":"Neuropediatrics"},{"title":"Neuropharmacology"},{"title":"Neuroprosthetics"},{"title":"Neurotrauma"},{"title":"Sleep and Chronobiology"},{"title":"Spinal Cord Medicine"},{"title":"Sports Neurology"},{"title":"Stroke"},{"title":"Teleneurology"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Frontiers in neurology","title":"Frontiers in neurology"}]}],"person":[{"family":"Heyse","display":"Heyse, Miriam","given":"Miriam","role":"aut"},{"role":"aut","display":"Tunkl, Christine","family":"Tunkl","given":"Christine"},{"given":"Katharina","family":"Drüschler","display":"Drüschler, Katharina","role":"aut"},{"family":"Berberich","display":"Berberich, Anne","given":"Anne","role":"aut"},{"display":"Zorn, Markus","family":"Zorn","given":"Markus","role":"aut"},{"role":"aut","given":"Peter A.","family":"Ringleb","display":"Ringleb, Peter A."},{"given":"Jürgen G.","family":"Okun","display":"Okun, Jürgen G.","role":"aut"},{"given":"Sibu","display":"Mundiyanapurath, Sibu","family":"Mundiyanapurath","role":"aut"}],"title":[{"title":"Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis","title_sort":"Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis"}],"physDesc":[{"extent":"6 S."}],"note":["Gesehen am 04.05.2021"],"recId":"1757052739","name":{"displayForm":["Miriam Heyse, Christine Schneider, Peter Monostori, Kathrin V. Schwarz, Jana Hauke, Katharina Drüschler, Anne Berberich, Markus Zorn, Peter A. Ringleb, Jürgen G. Okun and Sibu Mundiyanapurath"]}} 
SRT |a HEYSEMIRIATRIMETHYLA1920